Cell-free DNA copy number variations predict efficacy of immune checkpoint inhibitor-based therapy in hepatobiliary cancers.
Yang X, Hu Y, Yang K, Wang D, Lin J, Long J, Xie F, Mao J, Bian J, Guan M, Pan J, Huo L, Hu K, Yang X, Mao Y, Sang X, Zhang J, Wang X, Zhang H, Zhao H.
Yang X, et al. Among authors: hu y, hu k.
J Immunother Cancer. 2021 May;9(5):e001942. doi: 10.1136/jitc-2020-001942.
J Immunother Cancer. 2021.
PMID: 33972389
Free PMC article.